Medical News

RSS

USC Hospitalist Leadership Fellowship Program launched at ApolloMed

Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.

30 Mar 2015

Ebola epidemic reveals critical weaknesses in global public health system

In the year since the World Health Organization (WHO) was first notified of an outbreak of what proved to be Ebola virus disease in the west African country of Guinea, more than 24,000 cases have been reported and over 10,000 individuals have died - primarily in Guinea, Liberia and Sierra Leone.

30 Mar 2015

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.

30 Mar 2015

New faculty members join UNC Lineberger to help launch immunotherapy clinical trials

Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials testing an experimental treatment in which patients' own immune cells are genetically engineered to fight their cancer.

30 Mar 2015

CRT, BioInvent, and University of Southampton partner to develop new immunotherapy treatments for cancer

Cancer Research Technology, the commercialization and development arm of Cancer Research UK and BioInvent International today announce the start of a two-year research collaboration with leading antibody researchers at the University of Southampton.

30 Mar 2015

Columbia licenses exclusive worldwide rights to novel intra-vaginal ring technology

Columbia Laboratories, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, has licensed exclusive worldwide rights to a novel intra-vaginal ring technology for the delivery of one or more pharmaceuticals at different dosages and release rates in a single segmented ring.

30 Mar 2015

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its Phase II/III psoriasis trial for the Company's drug candidate CF101 did not achieve its primary endpoint.

30 Mar 2015

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

DURECT Corporation today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928, the lead molecule in DURECT's Epigenomic Regulator Program.

30 Mar 2015

Effective therapy enables immune system recovery in majority of children

Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment, according to a new study conducted by researchers at UCLA and other institutions in the U.S. and Brazil.

30 Mar 2015

DaVita Kidney Care celebrates its dietitians and social workers

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, is celebrating its more than 3,600 dietitians and social workers during March for their distinctive and important roles in patient care.

30 Mar 2015

Avoiding surgery may be better option for treating Type V AC joint injuries

Early surgery may not be the best treatment option for patients with Type V AC joint injuries, according to new research from Tripler Army Medical Center. The study, presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Specialty Day, showed military personnel returned to duty faster when surgery was not performed.

30 Mar 2015

One round of adenosine triphosphate turnover sufficient for SNARE complex disassembly

In 2013, James E. Rothman, Randy W. Schekman, and Thomas C. Südhof won the Nobel Prize in Physiology or Medicine for their discoveries of molecular machineries for vesicle trafficking, a major transport system in cells for maintaining cellular processes. Vesicle traffic acts as a kind of "home-delivery service" in cells.

30 Mar 2015

AJN honors six of Elsevier's nursing book titles with Book of the Year awards

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that six of its nursing book titles are recipients of the American Journal of Nursing (AJN) Book of the Year awards.

30 Mar 2015

Healthcare reform changes boost glucose testing in states with healthcare exchanges

A new study published in a major diabetes journal suggests that healthcare reform changes have boosted glucose testing in states that formed healthcare exchanges. The result confirms Kalorama Information's predictions on the topic.

From Quest Diagnostics 30 Mar 2015

$Two surgical methods safe, effective for healing distal femur fractures$

Two surgical methods safe, effective for healing distal femur fractures

A team of orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania has found that modern technology for healing distal femur fractures is as safe and effective as its more established alternative, without a potential shortfall of the older approach.

30 Mar 2015

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.

30 Mar 2015

Biosafe acquires ACTS do Brasil's biosafe-related business

After a successful partnership of 10 years with its local distributor ACTS do Brasil Ltda., effective immediately Biosafe has acquired all ACTS' Biosafe-related business, which has been spun off into a separate operating entity, Biosafe Brasil Distribuidora Ltda. Terms have not been disclosed.

30 Mar 2015

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders, announced today the submission to the Comisión Federal para la Protección contra Riesgos Sanitarios in Mexico for Kanuma as a treatment for patients with lysosomal acid lipase deficiency (LAL Deficiency), a rare genetic disease with significant morbidity and early mortality.

30 Mar 2015

Synthetic Biologics begins SYN-004 Phase 2a clinical trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced the initiation of a Phase 2a clinical trial to evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent C. difficile infection (CDI).

30 Mar 2015

European Commission clears Zimmer's proposed acquisition of Biomet

Zimmer Holdings, Inc. announced today that the European Commission has conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. The EC's clearance is conditioned upon Zimmer entering into agreements with a suitable buyer to divest certain assets comprising the remedy package previously submitted to the EC.

30 Mar 2015

Medical News

USC Hospitalist Leadership Fellowship Program launched at ApolloMed

Ebola epidemic reveals critical weaknesses in global public health system

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

New faculty members join UNC Lineberger to help launch immunotherapy clinical trials

CRT, BioInvent, and University of Southampton partner to develop new immunotherapy treatments for cancer

Columbia licenses exclusive worldwide rights to novel intra-vaginal ring technology

Can-Fite BioPharma's CF101Phase II/III psoriasis trial fails to meet primary endpoint

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

Effective therapy enables immune system recovery in majority of children

DaVita Kidney Care celebrates its dietitians and social workers

Avoiding surgery may be better option for treating Type V AC joint injuries

One round of adenosine triphosphate turnover sufficient for SNARE complex disassembly

AJN honors six of Elsevier's nursing book titles with Book of the Year awards

Healthcare reform changes boost glucose testing in states with healthcare exchanges

Two surgical methods safe, effective for healing distal femur fractures

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

Biosafe acquires ACTS do Brasil's biosafe-related business

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Synthetic Biologics begins SYN-004 Phase 2a clinical trial to prevent C. difficile infection

European Commission clears Zimmer's proposed acquisition of Biomet

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News